Ursprung des Netzwerks ersten Grades von Peter de Keizer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Peter de Keizer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RAPID MICRO BIOSYSTEMS, INC. | Industrial Machinery | Director/Board Member | |
Anchor Therapeutics, Inc.
Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | President | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
IMUGENE LIMITED | Biotechnology | Director/Board Member | |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Drugstore Chains | Corporate Officer/Principal | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Investment Managers | Private Equity Investor | |
Munich Biotech AG
Munich Biotech AG Pharmaceuticals: MajorHealth Technology Munich Biotech AG manufactures pharmaceuticals. The private company is based in Neuried, Germany. The German company was founded by Michael Teifel. | Pharmaceuticals: Major | Founder | |
The University of Chicago | College/University | Undergraduate Degree | |
Kentucky Wesleyan College | College/University | Undergraduate Degree | |
Technische Universität Darmstadt | College/University | Doctorate Degree | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Universität Konstanz | College/University | Doctorate Degree | |
TVM Capital Corp.
TVM Capital Corp. Investment ManagersFinance TVM Capital Corp (TVM Capital) is a venture capital subsidary of TVM Capital GmbH founded in 1986. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ANAVEX LIFE SCIENCES CORP. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Academy of Physicians In Clinical Research | Corporate Officer/Principal | ||
Association of Clinical Research Professionals
Association of Clinical Research Professionals Miscellaneous Commercial ServicesCommercial Services The Association of Clinical Research Professionals is a non-profit organization that provides over 50 online and in-person training programs for individual sale and institutional licensing. The non-profit company is based in Alexandria, VA and was founded by Lynn E. Regina. The company's courses cover good clinical practice (GCP) and specialized topics, including the anatomy of a protocol, hypothesis development, study design, subject safety, and data integrity risk considerations. The company also offers clinical trial insights research, a solution that combines market research capabilities with unprecedented access. With over 13,000 members, the organization represents, supports, and advocates for clinical research professionals. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The World Medical Association | Corporate Officer/Principal | ||
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services AEterna Zentaris GmbH engages in biopharmaceutical research. It specializes in the fields of oncology and endocrinology. The company is headquartered in Frankfurt, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member | |
Action Potential Venture Capital
Action Potential Venture Capital Investment ManagersFinance Action Potential Venture Capital (Action Potential Venture) is a venture capital subsidiary of GlaxoSmithKline Plc founded in 2013. The firm is headquartered in London, United Kingdom. | Investment Managers | Director/Board Member | |
ZappRx, Inc.
ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services ZappRx, Inc. develops prescription and prior authorization platform services. It provides healthcare providers, specialty pharmacies, biopharmacies, and security standards solutions. The company was founded by Zoe Barry in 2012 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
coramaze technologies GmbH
coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member | |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Gladius Pharmaceuticals Corp. operates as a biotechnology firm. The company is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Apollo Ventures Holding GmbH
Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg. | Investment Managers | Private Equity Investor Private Equity Investor Founder Founder | |
Palleon Pharma, Inc.
Palleon Pharma, Inc. BiotechnologyHealth Technology Palleon Pharma, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
SELLAS LIFE SCIENCES GROUP, INC. | Pharmaceuticals: Major | Founder | |
Samsara Therapeutics, Inc.
Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Samsara Therapeutics, Inc. operates as a biopharmaceutical platform company. It engages in the development and commercialization of first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases. The company was founded by Sebastian Aguiar in 2018 and is headquartered in Lewes, DE. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Cambrian BioPharma, Inc.
Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | Biotechnology | Founder | |
Genesis Research LLC
Genesis Research LLC Miscellaneous Commercial ServicesCommercial Services Genesis Research LLC provides pharmaceuticals services. It offers medical, scientific writing, simulation, artificial intelligence, machine learning, and natural language processing. The company was founded by Steven R. Arikian and Frank A. Corvino in 2009 and is headquartered in Hoboken, NJ. | Miscellaneous Commercial Services | Chief Executive Officer | |
Isterian Biotech, Inc.
Isterian Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Isterian Biotech, Inc. engages in the business of biotechnology services. The company is headquartered in Brooklyn, NY. | Miscellaneous Commercial Services | Chief Executive Officer | |
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor | |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Founder |
Statistik
International
Vereinigte Staaten | 37 |
Deutschland | 9 |
Kanada | 3 |
Australien | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 27 |
Finance | 8 |
Commercial Services | 8 |
Consumer Services | 7 |
Producer Manufacturing | 2 |
Operativ
Director/Board Member | 33 |
Corporate Officer/Principal | 13 |
Founder | 10 |
Private Equity Investor | 8 |
Chief Executive Officer | 8 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Jens Eckstein | 27 |
Angelos Stergiou | 13 |
James Peyer | 10 |
Marianne Mertens | 5 |
Michael Teifel | 5 |
Alexandra Bause | 3 |
Tobias Madl | 1 |
Marco Demaria | 1 |
- Börse
- Insiders
- Peter de Keizer
- Unternehmensverbindungen